News
Zacks.com on MSN14h
AZN Gets CHMP Nod for Imfinzi in Muscle-Invasive Bladder CancerAstraZeneca wins CHMP nod for Imfinzi combo in muscle-invasive bladder cancer, based on data from the phase III NIAGARA study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback